The invention provides a method of diagnosing, prognosing, staging, and/or
monitoring a mammalian amyloidogenic disorder or a predisposition thereto
by detecting a protein or polypeptide aggregate in the cortical and/or
supranuclear regions of an ocular lens of the mammal.